Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media

被引:60
|
作者
Turnovcova, Karolina [1 ,2 ,3 ]
Ruzickova, Katerina [1 ]
Vanecek, Vaclav [1 ,2 ,3 ]
Sykova, Eva [1 ,2 ,3 ]
Jendelova, Pavla [1 ,2 ,3 ]
机构
[1] Acad Sci Czech Republic, Inst Expt Med, Prague 14220 4, Czech Republic
[2] Charles Univ Prague, Dept Neurosci, Fac Med 2, Prague, Czech Republic
[3] Charles Univ Prague, Ctr Cell Therapy & Tissue Repair, Fac Med 2, Prague, Czech Republic
关键词
cell cycle; cell differentiation; cell-surface antigens; clinical trials; colony-forming units; population doubling time; FETAL CALF SERUM; IN-VITRO EXPANSION; STEM-CELLS; ANIMAL SERUM; THERAPY; ANTIBODIES; PROLIFERATION; DETERMINANT; SUBSTITUTE; EXPRESSION;
D O I
10.3109/14653240903188947
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background aims Human mesenchymal stromal cells (hMSC) are a promising tool for future clinical application, but their use requires rapid cell expansion in media suitable for clinical use. Therefore, we tested the influence of several culture media on colony formation, population doubling (PD) time, cell cycle and surface marker expression. Methods hMSC isolated from human bone marrow (BM) obtained from healthy donors were seeded and expanded in different culture media: alpha-minimum essential medium (MEM) supplemented with 2.5%, 5%, 10% or 20% fetal bovine serum (FBS), 5% or 10% human cord blood serum (hCBS), 5% or 10% human blood serum from AB adult donors (hABS), or mesenchymal stem cell growth medium (MSCGM (TM)). The number, diameter and total area of the colonies formed and PD time were determined, and the cell cycle and 16 surface markers were analyzed. Results Colony-forming efficiency was best in alpha-MEM/hCBS and alpha-MEM/hABS, good in MSCGM and worst in alpha-MEM/FBS. The shortest PD time was achieved in media enriched with human sera or MSCGM, while the time was increased in alpha-MEM/FBS. The largest proliferating fraction was seen in MSCGM followed by media enriched with human sera; the fraction was smallest in alpha-MEM/FBS. Staining for CD34, CD45, CD235a and CD271 was negative, while that for CD29, CD44, CD73, CD90, CD105 and human leukocyte antigen (HLA)-A, -B, -C was positive in all media tested. Media with human serum did not adversely affect the differentiation potential of hMSC, and differentiation into osteoblasts was enhanced. Conclusions The choice of serum influences hMSC expansion and cell properties; alpha-MEM supplemented with hABS seems to be a promising candidate for clinical use.
引用
收藏
页码:874 / 885
页数:12
相关论文
共 50 条
  • [41] Resveratrol mimics insulin activity in the adipogenic commitment of human bone marrow mesenchymal stromal cells
    Caldarelli, Ilaria
    Speranza, Maria Carmela
    Bencivenga, Debora
    Tramontano, Annunziata
    Borgia, Alessia
    Pirozzi, Anna Virginia Adriana
    Perrotta, Silverio
    Oliva, Adriana
    Della Ragione, Fulvio
    Borriello, Adriana
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 60 : 60 - 72
  • [42] Different mechanisms guide the antinociceptive effect of bone marrow-mononuclear cells and bone marrow-mesenchymal stem/stromal cells in trigeminal neuralgia
    Costa, Catarina Milena Mota
    Santos, Dourivaldo Silva
    Opretzka, Luiza Carolina Franca
    Silva, Gessica Sabrina de Assis
    Santos, Girlaine Cafe
    Evangelista, Afranio Ferreira
    Soares, Milena Botelho Pereira
    Villarreal, Cristiane Flora
    LIFE SCIENCES, 2024, 354
  • [43] The Metastatic Bone Marrow Niche in Neuroblastoma: Altered Phenotype and Function of Mesenchymal Stromal Cells
    Hochheuser, Caroline
    van Zogchel, Lieke M. J.
    Kleijer, Marion
    Kuijk, Carlijn
    Tol, Simon
    van der Schoot, C. Ellen
    Voermans, Carlijn
    Tytgat, Godelieve A. M.
    Timmerman, Ilse
    CANCERS, 2020, 12 (11) : 1 - 20
  • [44] Human Bone Marrow Mesenchymal Stromal Cells Promote Bone Regeneration in a Xenogeneic Rabbit Model: A Preclinical Study
    Francisco Blanco, Juan
    Garcia-Brinon, Jesus
    Benito-Garzon, Lorena
    Pescador, David
    Muntion, Sandra
    Sanchez-Guijo, Fermin
    STEM CELLS INTERNATIONAL, 2018, 2018
  • [45] Proliferative Potential of Multipotent Mesenchymal Stromal Cells from Human Bone Marrow
    Zhironkina, O. A.
    Shipounova, I. N.
    Bigildeev, A. E.
    Sats, N. V.
    Petinati, N. A.
    Drize, N. I.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 152 (04) : 543 - 547
  • [46] Study of Genetic Stability of Human Bone Marrow Multipotent Mesenchymal Stromal Cells
    Nikitina, V. A.
    Osipova, E. Yu.
    Katosova, L. D.
    Rumyantsev, S. A.
    Skorobogatova, E. V.
    Shamanskaya, T. V.
    Bochkov, N. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 150 (05) : 627 - 631
  • [47] IDENTIFICATION OF BIOMARKERS FOR QUALITY CONTROL OF HUMAN BONE MARROW MESENCHYMAL STROMAL CELLS
    De Santana, T. A.
    Gomez, N. P.
    Santos, G. C.
    Azevedo, C. M.
    Meira, C. S.
    Damasceno, P. F.
    Soares, M. B.
    CYTOTHERAPY, 2024, 26 (06) : S42 - S43
  • [48] Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells
    Xu, Maojia
    Shaw, Georgina
    Murphy, Mary
    Barry, Frank
    STEM CELLS, 2019, 37 (06) : 754 - 765
  • [49] Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia
    Mcclain-Caldwell, Ian
    Vitale-Cross, Lynn
    Mayer, Balazs
    Krepuska, Miklos
    Boyajian, Michael
    Myneni, Vamsee
    Martin, Daniel
    Nemeth, Krisztian
    Mezey, Eva
    CYTOTHERAPY, 2018, 20 (12) : 1437 - 1444
  • [50] Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells
    Andre, Thibaud
    Najar, Mehdi
    Stamatopoulos, Basile
    Pieters, Karlien
    Pradier, Olivier
    Bron, Dominique
    Meuleman, Nathalie
    Lagneaux, Laurence
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (02) : 213 - 224